Healthcare Bioconvergence Global Market Report 2022: Sector to Reach $215.2 Billion by 2030 at a CAGR of 7.4%
March 13, 2023 11:38 ET
|
Research and Markets
Dublin, March 13, 2023 (GLOBE NEWSWIRE) -- The "Healthcare Bioconvergence Market Size, Share & Trends Analysis Report By Application (Drug Discovery, Regenerative Medicine, Bioelectronics), By...
electroCore Announces Poster to be Presented at the 2023 American Academy of Neurology Annual Scientific Meeting
March 13, 2023 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., March 13, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that data from a sham controlled...
electroCore to Participate at 35th Annual Roth Conference
March 09, 2023 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, March 09, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR) a commercial-stage bioelectronic medicine and wellness company, today announced that electroCore’s...
electroCore Regains Compliance with Nasdaq Listing Requirements
March 07, 2023 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., March 07, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received notice from...
electroCore to Announce Fourth Quarter and Year Ended December 31, 2022 Financial Results on Wednesday, March 8
March 01, 2023 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., March 01, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial...
The Dan Lewis Foundation for Brain Regeneration Research Announces First Annual DLF Prize to Be Awarded Spring 2023
February 23, 2023 11:00 ET
|
The Dan Lewis Foundation for Brain Regeneration Research (danlewisfoundation.org)
DENVER, Feb. 23, 2023 (GLOBE NEWSWIRE) -- The Dan Lewis Foundation for Brain Regeneration Research (the DLF) happily announces the 2023 DLF Prize. This $15,000 prize will be awarded to an early...
electroCore, Inc. Announces Exclusive Distribution Agreement with Byond Healthcare Pty Ltd, South Africa
February 21, 2023 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., Feb. 21, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced an agreement with...
electroCore Expands Intellectual Patent Portfolio for nVNS Technology
February 16, 2023 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., Feb. 16, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that the United States Patent and...
electroCore Completes Sale of New Jersey Tax Benefits
February 15, 2023 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., Feb. 15, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has completed the sale of...
electroCore Announces Reverse Stock Split
February 14, 2023 10:30 ET
|
electroCore, Inc.
ROCKAWAY, N.J., Feb. 14, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (the “Company”), a commercial-stage bioelectronic medicine and wellness company, today announced a planned reverse...